European approval for AnteoTech's COVID-19 test

April 13, 2021 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

AnteoTech (ASX:ADO) has announced it has received CE Mark registration for its EuGeni Reader and the in vitro rapid diagnostic test for the detection of SARS-CoV-2 nucleocapsid antigen, the COVID-19 ART. …

Subscribe now to continue reading.

Latest Video

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - Latest News
Former minister joins DBG Health board as company broadens healthcare ambition
August 12, 2026 - Latest News
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 - Latest News
Patients welcome the timely PBS listing of rare cancer therapy
August 12, 2026 - Latest News
A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making
August 12, 2026 - Latest News

European approval for AnteoTech's COVID-19 test

This is a preview of subscriber content

Latest Video

Most Read

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Former minister joins DBG Health board as company broadens healthcare ambition

US childhood vaccine move away from combinations contrasts with Australia’s national schedule

Patients welcome the timely PBS listing of rare cancer therapy

A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making

New Stories

An institution dominated by very clever people, but where is the wisdom?

A plain language version of these dreadful and useless documents

CUREator+ backs six Australian startups with $13.5 million to advance new health technologies

Medicines Australia appoints former AbbVie executive to key leadership role

VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea

Survey exposes deep gaps in neurological care across Australia

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Sign In

European approval for AnteoTech's COVID-19 test

This is a preview of subscriber content

Latest Video

Most Read

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product

Former minister joins DBG Health board as company broadens healthcare ambition

US childhood vaccine move away from combinations contrasts with Australia’s national schedule

Patients welcome the timely PBS listing of rare cancer therapy

A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making

Follow Us

New Stories

An institution dominated by very clever people, but where is the wisdom?

A plain language version of these dreadful and useless documents

CUREator+ backs six Australian startups with $13.5 million to advance new health technologies

Medicines Australia appoints former AbbVie executive to key leadership role

VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea

Survey exposes deep gaps in neurological care across Australia

Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product